OR WAIT 15 SECS
The International Association of Healthcare Central Service Materiel Management (IAHCSMM) presents the following frequently asked questions and answers regarding the ASP STERRADÂ® CYCLESUREÂ® 24 Biological Indicator (BI) (P/N 14324) Recall:
1.What is the STERRADÂ® CYCLESUREÂ® 24 Biological Indicator (BI)? How is it used?
The STERRADÂ® CYCLESUREÂ® 24 BI is used to provide evidence that proper sterilization conditions have been achieved in just 24 hours.
2. Why did ASP initiate a voluntary recall for certain lots of STERRADÂ® CYCLESUREÂ® 24 BI?
ASP recently determined that it does not have adequate data to support the entire duration of the products labeled shelf-life. As a result, ASP has issued a global product recall to revise the expiration dates of STERRADÂ® CYCLESUREÂ® 24 BI effective July 3, 2012.
3. Is there a health and safety risk to patients?
Â Use of expired product may result in not being able to verify proper sterilization conditions. While the number of individual patients at risk for exposure to infections may be high, the risk of a life-threatening infection to an individual patient is very low, given that this biological indicator is only one of three sterilization system monitors and the window of possible exposure to the malfunctioning STERRADÂ® CYCLESUREÂ® 24 BI is relatively short.
4. Should I inform patients that were treated with an improperly sterilized medical device?
FDA has recommended that healthcare facilities follow their procedures. Also, a recent FDA Safety Communication stated that while the number of individual patients at risk for exposure to infections may be high, the risk of a life-threatening infection for an individual patient is very low, given that the STERRADÂ® CYCLESUREÂ® 24 BI is only one of three sterilization system monitors part of STERRADÂ® Systems, and the window of possible exposure to malfunctioning product is relatively short.
5. Where can I find the FDA Safety Communication?
Â The FDA Safety Communication, posted on July 3, 2012, can be accessed here:
6. Should my healthcare facility re-sterilize medical devices that were sterilized with an expired STERRADÂ® CYCLESUREÂ® 24 BI?
Yes. ASP is recommending that these devices be re-sterilized.
7. What do I need to do now?
Â ASP is asking customers to take inventory of their STERRADÂ® CYCLESUREÂ® 24 BI supply and review each case against the revised shelf-life for the product pursuant to the instructions set forth in the What Action Is Required section of the Customer Letter (CL107822_A). Customers should discontinue the use of product from certain lots of STERRADÂ® CYCLESUREÂ® 24 BIs that exceed the newly determined expiration date and return it according to instructions in the customer letter for replacement product.
8.What if I have a lot number that is not listed on the customer letter?
The recall of STERRADÂ® CYCLESUREÂ® 24 BI affects only certain lots of product that were shipped beginning December 2011. Affected lots of STERRADÂ® CYCLESUREÂ® 24 Biological Indicator (P/N AD-120197-01-US_A 14324) product, which are also components of STERRADÂ® Test Packs (P/Ns 20123, 14325, 20239 and 20103), are listed on the customer letter that can be found on www.aspjj.com. If your lot number does not appear on the list provided with the customer letter, you may proceed to use the STERRADÂ® CYCLESUREÂ® 24 Biological Indicator (P/N 14324) product in accordance with the provided instructions for use (IFU).
9. How should I re-label the product with the newly calculated expiration date?
Â Please follow the instructions as set forth in the What Action Is Required section of the Customer Letter (CL-107822_A). ASP recommends that your facility manually re-label the non-expired product boxes with the newly calculated expiration date so that your inventory is correctly labeled for your use. Note, manually re-label the non-expired product boxes.
10. I receive my product from a distributor or other third-party. Will they be responsible for manually re-labeling the product with the newly calculated expiration date?
ASP does not sell STERRADÂ® CYCLESUREÂ® 24 Biological Indicator through distribution channels. Individual hospitals should follow the directions indicated in the What Action Is Required section of the Customer Letter (CL107822_A):
Provide the notice to anyone in their facility that needs to be informed
Maintain a copy of this notice with the affected product
If any of the STERRADÂ® CYCLESUREÂ® 24 Biological Indicator (BI) product has been forwarded to another facility, contact that facility and arrange return
Maintain awareness of this notice until expired product listed above has been returned
To read the rest of the FAQs, visit: http://www.iahcsmm.org/CurrentIssues/ASP-FAQ.html